Orexigen Therapeutics, Inc. (NASDAQ:OREX)

CAPS Rating: 1 out of 5

A biopharmaceutical company focused on the development of pharmaceutical product candidates for the treatment of central nervous system, disorders, with an initial focus on obesity.

OREX News and Commentary

View All OREX News and Commentary

Caps

How do you think OREX will perform against the market?

Add Stock to CAPS Watchlist

All Players

209 Outperform
62 Underperform
 

All-Star Players

34 Outperform
18 Underperform
 

Wall Street

9 Outperform
3 Underperform
 

Top OREX Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

mario60045 (38.81)
Submitted December 02, 2015

With European approval, news of a marketing partner will boost the price up.

chris293 (64.30)
Submitted May 21, 2015

Even some fools agree this OREX is not the king of Biotech, but its losses are declining. The lawsuit is a big negative if they lose so they have to really pull a rabbit out of their hat.

OREX VS S&P 500 (SPY)

Recent Community Commentary

Read the most recent pitches from players about OREX.

Recs

0
Member Avatar SmartAce (99.93) Submitted: 11/8/2016 3:25:30 PM : Underperform Start Price: $2.14 OREX Score: -6.16

I think that whoever wins this years election will most likely be our next President.

Recs

0
Member Avatar genedom (95.76) Submitted: 7/28/2016 4:31:32 PM : Outperform Start Price: $3.38 OREX Score: -37.23

Undervalue play. Should double by year end.

Recs

1
Member Avatar mario60045 (38.81) Submitted: 12/1/2015 11:02:48 PM : Outperform Start Price: $23.10 OREX Score: -106.07

With European approval, news of a marketing partner will boost the price up.

Leaderboard

Find the members with the highest scoring picks in OREX.

Score Leader

qubit15

qubit15 (< 20) Score: +302.76

The Score Leader is the player with the highest score across all their picks in OREX.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
qubit15 < 20 1/21/2009 Underperform NS $43.50 -94.02% +208.74% +302.76 0 Comment
vulturecapitol < 20 1/12/2009 Underperform 1Y $50.40 -94.84% +183.06% +277.90 0 Comment
JeffBone 70.12 12/8/2008 Underperform NS $45.10 -94.24% +179.62% +273.86 0 Comment
shephunts 30.98 7/1/2009 Underperform 5Y $52.30 -95.03% +168.88% +263.91 0 Comment
gmxBatteringRam 29.36 6/5/2009 Underperform 3W $42.00 -93.81% +164.53% +258.34 0 Comment
BASSTRAX 21.21 9/9/2009 Underperform 3Y $85.30 -96.95% +141.37% +238.32 0 Comment
l00weredblaze < 20 10/5/2009 9/30/2010 Underperform 5Y $90.40 -97.12% +140.14% +237.26 0 Comment
anticitrademix2 < 20 11/2/2009 Underperform 5Y $68.20 -96.19% +137.30% +233.49 0 Comment
anticitrademix < 20 11/2/2009 Underperform 5Y $68.20 -96.19% +137.30% +233.49 0 Comment
longtermgrowth09 < 20 12/17/2009 Underperform 5Y $76.20 -96.59% +123.18% +219.76 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackWellsFargo 93.29 4/25/2014 Outperform NS $57.50 -95.48% +31.99% -127.47 0 Comment
TrackBofASec 94.61 6/21/2013 Outperform NS $60.60 -95.71% +54.79% -150.50 0 Comment
TrackCreditSuiss 91.49 9/6/2012 Outperform NS $55.10 -95.28% +74.31% -169.59 0 Comment
TrackPoisedTo < 20 6/29/2012 Underperform 5Y $60.70 -95.72% +82.77% +178.48 0 Comment
TrackJPMorgan 89.02 6/28/2012 Outperform NS $56.40 -95.39% +86.79% -182.18 0 Comment
TrackJMP 84.27 9/21/2011 Outperform NS $22.50 -88.44% +106.23% -194.67 0 Comment
TrackRodmanRen < 20 12/6/2010 Underperform NS $47.70 -94.55% +101.50% +196.05 0 Comment
TrackJefferies 85.28 3/4/2010 Outperform NS $69.70 -96.27% +119.74% -216.01 0 Comment
TrackJimCramer 84.57 10/2/2009 Underperform 3W $90.40 -97.12% +141.10% +238.22 0 Comment
TrackRodmanRen < 20 6/24/2009 Outperform NS $47.30 -5.92% +18.68% -24.60 7/16/2010 @ $44.50 0 Comment
TrackLeerinkSwan 98.53 8/25/2008 Outperform NS $115.10 -97.74% +97.96% -195.70 0 Comment
TrackCowenandCo 86.14 4/3/2008 Outperform NS $105.60 -97.54% +88.41% -185.95 0 Comment
TrackLazardCapit 81.45 2/6/2008 Outperform NS $116.70 -97.77% +91.49% -189.26 0 Comment
TrackCanaccord 67.78 2/4/2008 Outperform NS $115.90 -77.39% -6.13% -71.26 2/1/2011 @ $26.20 0 Comment
TrackJPMorgan 89.02 6/7/2007 Outperform NS $177.60 -61.82% -21.61% -40.22 4/30/2010 @ $67.80 0 Comment
TrackJMP 84.27 6/6/2007 Outperform NS $183.50 -86.24% -14.46% -71.78 2/1/2011 @ $25.26 0 Comment

Featured Broker Partners